Table 3. . Blood half life and tumor accumulation.
Nanoparticle | Surface coating | Blood half life | Tumor accumulation |
---|---|---|---|
2 nm Gold nanoparticles [38] 2 nm Gold nanoparticles 2 nm Gold nanoparticles |
TEG-Hydroxyl TEG-Amine TEG-Carboxyl |
5 h 24 h 18 m |
25 μg† Au/g tumor 5 μg† Au/g tumor 15 μg† Au/g tumor |
22 nm Gold nanoparticles [48] 40 nm Gold nanoparticles 99 nm Gold nanoparticles 82 nm Gold nanoparticles 61 nm Gold nanoparticles |
PEG2000-SH PEG2000-SH PEG10,000-SH PEG10,000-SH PEG5000-SH |
2.5 h 4 h 7.2 h 11.6 h 16.5 h |
0.3% injected dose·h/g 15.8% injected dose·h/g 17.9% injected dose·h/g 20.4% injected dose·h/g 26.5% injected dose·h/g |
Gold nanorods (hd = 42) [62] Gold nanorods (hd = 44) Gold nanorods (hd = 22) |
SiO2-PEG SiO2-BSA BSA |
18.6 m 3.3 m 34 s |
0.83% injected dose 0.45% injected dose 0.3% injected dose |
Gold nanorods (13nm × 47nm) [63] | PEG | 17 h | 7% injected dose/g |
Studies in the table are limited to gold nanoparticle studies that used inductively coupled plasma methodologies to quantify both blood circulation and tumor accumulation.
†Estimated from bar graphs in the publication.
PEG: Polyethylene glycol, TEG: Tetraethylene glycol.